CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Angina - stable - Management
Which calcium-channel blocker is recommended?
- Monotherapy (when a beta-blocker is contraindicated or not tolerated): a rate-limiting calcium-channel blocker (CCB) may be preferred.
- Combination therapy
- People taking a beta-blocker: prescribe a dihydropyridine (amlodipine, felodipine, or modified-release nifedipine).
- People not taking a beta-blocker: a rate-limiting CCB may be preferred.
- If the person has concomitant heart failure: prescribe a amlodipine or felodipine.
In depth
© NHS Institute for Innovation and Improvement